Clinical Trial Update: Intravenous VEGF Trap in Treating Patients With Relapsed or Refractory Advanced Solid Tumors or Non-Hodgkin's Lymphoma [Phase 1]

View source ↗

Summary

A Phase 1 trial update of intravenous aflibercept (VEGF trap) in patients with relapsed or refractory advanced solid tumors or non-Hodgkin lymphoma has complete…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-hodgkin Lymphoma

Drugs mentioned

• Zaltrap (ramucirumab)

Snippet

Sponsor: Regeneron Pharmaceuticals | Conditions: Cancer | Phase 1 | Status: COMPLETED